JP2021505647A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505647A5 JP2021505647A5 JP2020532696A JP2020532696A JP2021505647A5 JP 2021505647 A5 JP2021505647 A5 JP 2021505647A5 JP 2020532696 A JP2020532696 A JP 2020532696A JP 2020532696 A JP2020532696 A JP 2020532696A JP 2021505647 A5 JP2021505647 A5 JP 2021505647A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- ethyl
- alkyl
- group
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023211061A JP2024028984A (ja) | 2017-12-12 | 2023-12-14 | 化学療法誘発性の医原性疼痛の治療に使用するためのＣ５ａＲ阻害薬 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17206813.2A EP3498269A1 (en) | 2017-12-12 | 2017-12-12 | C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain |
| EP17206813.2 | 2017-12-12 | ||
| PCT/EP2018/084277 WO2019115493A2 (en) | 2017-12-12 | 2018-12-11 | C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023211061A Division JP2024028984A (ja) | 2017-12-12 | 2023-12-14 | 化学療法誘発性の医原性疼痛の治療に使用するためのＣ５ａＲ阻害薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505647A JP2021505647A (ja) | 2021-02-18 |
| JP2021505647A5 true JP2021505647A5 (enExample) | 2022-01-11 |
| JP7430141B2 JP7430141B2 (ja) | 2024-02-09 |
Family
ID=60673204
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532696A Active JP7430141B2 (ja) | 2017-12-12 | 2018-12-11 | 化学療法誘発性の医原性疼痛の治療に使用するためのＣ５ａＲ阻害薬 |
| JP2023211061A Pending JP2024028984A (ja) | 2017-12-12 | 2023-12-14 | 化学療法誘発性の医原性疼痛の治療に使用するためのＣ５ａＲ阻害薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023211061A Pending JP2024028984A (ja) | 2017-12-12 | 2023-12-14 | 化学療法誘発性の医原性疼痛の治療に使用するためのＣ５ａＲ阻害薬 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12102607B2 (enExample) |
| EP (2) | EP3498269A1 (enExample) |
| JP (2) | JP7430141B2 (enExample) |
| KR (2) | KR20200108839A (enExample) |
| CN (1) | CN111511363A (enExample) |
| AU (1) | AU2018385364B2 (enExample) |
| BR (1) | BR112020009972A2 (enExample) |
| CA (1) | CA3082762A1 (enExample) |
| IL (1) | IL275132A (enExample) |
| MA (1) | MA51128A (enExample) |
| RU (1) | RU2020122678A (enExample) |
| SG (1) | SG11202004322VA (enExample) |
| WO (1) | WO2019115493A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4059497A1 (en) * | 2021-03-17 | 2022-09-21 | Dompé farmaceutici S.p.a. | C5ar1 inhibitors for treating hypersensitivity reactions to taxanes |
| WO2022195017A1 (en) * | 2021-03-17 | 2022-09-22 | Dompe' Farmaceutici Spa | C5ar1 inhibitors for treating hypersensitivity reactions to taxanes |
| EP4397306A1 (en) * | 2023-01-05 | 2024-07-10 | Dompe' Farmaceutici S.P.A. | C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1776336E (pt) * | 2004-03-23 | 2009-12-18 | Dompe Spa | Derivados de ácido 2-fenilpropiónico e composições farmacêuticas que os contêm |
| PL1951663T3 (pl) | 2005-11-24 | 2017-01-31 | Dompé Farmaceutici S.P.A. | Pochodne (R)-aryloalkiloaminowe i zawierające je kompozycje farmaceutyczne |
| ES2551095T3 (es) | 2007-07-19 | 2015-11-16 | Lundbeck, H., A/S | Amidas heterocíclicas de 5 miembros y compuestos relacionados |
| ES2361233T3 (es) * | 2007-10-18 | 2011-06-15 | Dompé S.p.A. | Derivados (r)-4-(heteroaril)feniletilo y composiciones farmacéuticas que los contienen. |
| JP7049254B2 (ja) * | 2016-01-15 | 2022-04-06 | ドンペ ファーマスーチシ ソシエタ ペル アチオニ | 化学療法で誘導される末梢神経障害の治療に使用するためのｉｌ－８阻害剤 |
| EP3192504A1 (en) * | 2016-01-15 | 2017-07-19 | Dompé farmaceutici S.p.A. | Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy |
-
2017
- 2017-12-12 EP EP17206813.2A patent/EP3498269A1/en not_active Withdrawn
-
2018
- 2018-12-11 KR KR1020207019986A patent/KR20200108839A/ko not_active Ceased
- 2018-12-11 CA CA3082762A patent/CA3082762A1/en active Pending
- 2018-12-11 KR KR1020257008744A patent/KR20250041193A/ko active Pending
- 2018-12-11 AU AU2018385364A patent/AU2018385364B2/en active Active
- 2018-12-11 MA MA051128A patent/MA51128A/fr unknown
- 2018-12-11 SG SG11202004322VA patent/SG11202004322VA/en unknown
- 2018-12-11 WO PCT/EP2018/084277 patent/WO2019115493A2/en not_active Ceased
- 2018-12-11 EP EP18825596.2A patent/EP3723744A2/en active Pending
- 2018-12-11 BR BR112020009972-4A patent/BR112020009972A2/pt unknown
- 2018-12-11 US US16/769,892 patent/US12102607B2/en active Active
- 2018-12-11 RU RU2020122678A patent/RU2020122678A/ru unknown
- 2018-12-11 CN CN201880080117.1A patent/CN111511363A/zh active Pending
- 2018-12-11 JP JP2020532696A patent/JP7430141B2/ja active Active
-
2020
- 2020-06-04 IL IL275132A patent/IL275132A/en unknown
-
2023
- 2023-12-14 JP JP2023211061A patent/JP2024028984A/ja active Pending
-
2024
- 2024-08-09 US US18/799,076 patent/US20240398731A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006500348A5 (enExample) | ||
| JP2017523972A5 (enExample) | ||
| RU2454415C2 (ru) | Производное индола | |
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| JP2014511869A5 (enExample) | ||
| RU2492167C2 (ru) | Производные аминотриазола в качестве агонистов alх | |
| JP2010504280A5 (enExample) | ||
| RU2013138569A (ru) | Антагонисты рецептора минералокортикоидов | |
| RU2501791C2 (ru) | Производное триазола или его соль | |
| JP2021505647A5 (enExample) | ||
| JP2002540155A5 (enExample) | ||
| JP2005536458A5 (enExample) | ||
| RU2011134631A (ru) | Вызывающие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний | |
| CA2478068A1 (en) | Dihydropyrazole compounds useful for treating or preventing cancer | |
| JP2013530240A5 (enExample) | ||
| JP2010215644A5 (enExample) | ||
| HRP20170357T1 (hr) | Sastavi i postupci za liječenje poremećaja zbog konzumacije alkohola, bolova i ostalih bolesti | |
| JP2005517006A5 (enExample) | ||
| RU2006127575A (ru) | Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
| JP2007523905A5 (enExample) | ||
| WO2006076575B1 (en) | Substituted biaryl compounds as factor xia inhibitors | |
| JP2007519735A5 (enExample) | ||
| RU2011105151A (ru) | Азольные соединения | |
| RU2006125446A (ru) | Производные n-замещенного n-сульфониламиноциклопропана и их фармацевтическое применение | |
| HRP20160421T1 (hr) | Derivat azola |